Axonis Therapeutics Announces $115 Million Series A Financing Oct 30, 2024 06:00AM
venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies Aug 1, 2024 08:00AM
Form SC 13G/A Checkmate Pharmaceutical Filed by: venBio Global Strategic Fund II L.P. Jun 7, 2022 04:16PM
Form 4 Checkmate Pharmaceutical For: May 13 Filed by: venBio Global Strategic Fund II L.P. May 17, 2022 05:12PM
Form 4 Checkmate Pharmaceutical For: May 05 Filed by: venBio Global Strategic Fund II L.P. May 9, 2022 06:59PM


May 5, 2022 04:23PM Form SC 13G/A Checkmate Pharmaceutical Filed by: venBio Global Strategic Fund II L.P.
May 4, 2022 07:31PM Form 4 Checkmate Pharmaceutical For: May 02 Filed by: venBio Global Strategic Fund II L.P.
Apr 29, 2022 05:59PM Form 4 Checkmate Pharmaceutical For: Apr 27 Filed by: venBio Global Strategic Fund II L.P.
Apr 26, 2022 06:41PM Form 4 Checkmate Pharmaceutical For: Apr 22 Filed by: venBio Global Strategic Fund II L.P.
Oct 6, 2020 03:19PM Form SC 13G Checkmate Pharmaceutical Filed by: venBio Global Strategic Fund II L.P.
Aug 12, 2020 09:01PM Form 4 Checkmate Pharmaceutical For: Aug 11 Filed by: venBio Global Strategic Fund II L.P.
Aug 6, 2020 09:04PM Form 3 Checkmate Pharmaceutical For: Aug 06 Filed by: venBio Global Strategic Fund II L.P.